Crosstalk in multidisciplinary approaches for evidence-based medicine
Evidence-based medicine (EBM) provides care to patients using the appropriate use of the best available evidence. EBM has increased due to the advancement of clinical measurements, research design, and efficient data analysis techniques. A multidisciplinary approach and the capacity of available evidence have made EBM more reliable than ever. The current development's objective is to achieve high-quality clinical research in the field of clinical decision-making.
Now EBM is laced with new clinician skills that provide the edge in collecting vital information about patients' diagnosis, therapy, prognosis, clinical trial studies, and healthcare issues. Therefore, crosstalk in EBM with interdisciplinary consideration has become essential to better understand and serve patients and our society. Certainly, crosstalk on EBM in a multidisciplinary approach will provide options for treatments, medications, harmful side effects, and any potential risks involved.
Guest editors
Dr. Woon-Man Kung(Taipei Tzu Chi Hospital)
Dr. Woon-Man Kung now serves as a Consultant Neurosurgeon in the Division of Neurosurgery, Department of Surgery, Taipei Tzu Chi Hospital (TCH), Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan, as well as an Adjunct Associate Professor in the Department of Exercise and Health Promotion, College of Kinesiology and Health, Chinese Culture University (CCU), Taipei, Taiwan.
Dr. Yao-Chin Wang(Min-Sheng General Hospital)
Dr. Yao-Chin Wang received the Ph.D. degree from the College of Medical Science and Technology (CoMST), Graduate Institute of Biomedical Informatics, Taipei Medical University (TMU), Taipei City, Taiwan, in 2018. He has served as an attending Physician with the Department of Emergency, Min-Sheng General Hospital, Taoyuan City, Taiwan.
Dr. Sunil Kumar(Nottingham Trent University)
Dr. Sunil Kumar received his Ph.D. in Pharmacy from India in 2012. He worked as a scientist-IPR (Intellectual Property Rights) at pharmaceutical R&D. He was employed as an Assistant professor at ISF College of Pharmacy, Moga, India. He was awarded a postdoctoral fellowship by National Science Council (NSC), Taiwan. His research is mainly based on medicinal and natural product chemistry, specializing in anti-inflammatory and anti-cancer drug design.